Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same author

Cardio-Obstetrics Care: Challenging Scenarios in Heart Failure and Future Directions.

European journal of heart failure·2026
Same author

Diagnostic Yield of Exome Sequencing in Patients With Congenital Heart Disease From Southern Africa.

Circulation. Genomic and precision medicine·2026
Same author

Heart Failure in Pregnancy: Where the 2025 ESC Guidelines "Cardiovascular disease and pregnancy" Illuminate-and Where Shadows Remain.

European journal of heart failure·2026
Same author

European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection Fraction.

European journal of heart failure·2026
Same author

Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC.

European journal of heart failure·2026

Related Experiment Video

Updated: May 10, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.2K

Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).

R M Bolman1, P Zilla2, F Beyersdorf3

  • 1Division of Cardio-Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, USA.

Asian Cardiovascular & Thoracic Annals
|June 14, 2024
PubMed
Summary

The Cardiac Surgery Intersociety Alliance (CSIA) established pilot programs in Mozambique and Rwanda to build sustainable cardiac surgery capacity. These initiatives successfully increased case numbers, government commitment, and infrastructure, demonstrating a viable model for global cardiac surgery development.

Keywords:
Developing countriesSustainable cardiac surgerycardiac surgerysurgery

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.4K

Related Experiment Videos

Last Updated: May 10, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.2K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.4K

Area of Science:

  • Global Health
  • Cardiovascular Surgery
  • Developing Economies

Background:

  • Significant unmet need for cardiac surgery in developing regions.
  • Disparity in access to essential cardiovascular care globally.
  • Need for sustainable, localized cardiac surgical capacity.

Purpose of the Study:

  • To address the disparity in cardiac surgical care access.
  • To advocate for and establish sustainable cardiac surgical capacity in low-income countries.
  • To implement and evaluate pilot programs for cardiac surgery development.

Main Methods:

  • Formation of the Cardiac Surgery Intersociety Alliance (CSIA).
  • Global needs assessment identifying rheumatic heart disease as a primary pathology.
  • Selection and mentorship of pilot sites in Mozambique and Rwanda.
  • Establishment of training and mentorship agreements with partner institutions.

Main Results:

  • Successful implementation of pilot programs in Mozambique and Rwanda.
  • Increased cardiac surgery case numbers and government commitment in pilot sites.
  • Significant infrastructure upgrades and industry/donor engagement.
  • Demonstrated sustainability and capacity-building in local cardiac surgical programs.

Conclusions:

  • The CSIA model effectively builds sustainable cardiac surgical capacity in developing countries.
  • Pilot programs in Mozambique and Rwanda show significant positive outcomes.
  • Expanding the CSIA 'Seal of Approval' can further advance global cardiac surgery development.